SK Bioscience Co.,Ltd
A biopharma firm developing and manufacturing vaccines and offering CDMO services.
302440 | KO
Overview
Corporate Details
- ISIN(s):
- KR7302440003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 310, 성남시
- Website:
- https://www.skbioscience.com/
- Sector:
- Manufacturing
Description
SK Bioscience is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines and biological products. Spun off from SK Chemicals in 2018, the company develops its own pipeline of vaccines, including cell-culture-based influenza vaccines and a COVID-19 vaccine, utilizing its established R&D and production platforms. In addition to its proprietary products, SK Bioscience provides global Contract Development and Manufacturing Organization (CDMO) services, offering end-to-end support from process development to large-scale commercial manufacturing for international partners. The company is dedicated to promoting public health by providing innovative preventative solutions to address global health challenges.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-08 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.3 KB | ||
| 2023-02-08 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.5 KB | ||
| 2023-02-08 00:00 |
신규시설투자등
|
Korean | 8.2 KB | ||
| 2023-01-19 00:00 |
결산실적공시예고(안내공시)
|
Korean | 4.4 KB | ||
| 2023-01-19 00:00 |
기업설명회(IR)개최(안내공시)
|
Korean | 6.2 KB | ||
| 2023-01-16 00:00 |
투자판단관련주요경영사항(노바백스 코로나19 백신 국내 품목허가 변경 승인(부스터샷 적응증 추가))
|
Korean | 7.6 KB | ||
| 2023-01-05 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.1 KB | ||
| 2022-12-29 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.0 KB | ||
| 2022-12-28 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 14.6 KB | ||
| 2022-11-30 00:00 |
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 9.1 KB | ||
| 2022-11-29 00:00 |
투자판단관련주요경영사항(COVID-19 백신 GBP510의 이종 부스터샷 콜롬비아 제3상 임상시험계획(IND) 신청)
|
Korean | 10.9 KB | ||
| 2022-11-24 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 11.2 KB | ||
| 2022-11-23 00:00 |
풍문또는보도에대한해명
|
Korean | 5.0 KB | ||
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 776.6 KB | ||
| 2022-10-31 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB |
Automate Your Workflow. Get a real-time feed of all SK Bioscience Co.,Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SK Bioscience Co.,Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SK Bioscience Co.,Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
